• KOL
  • Her2 Blockade
  • Her2 Blockade



    Her2 Blockade: Top KOLs in the world

    Jose M Baselga #1
    Jose M Baselga
    Memorial Sloan Kettering Cancer Center, New York, NY. | Astr
    Known for Monoclonal Antibodies | Advanced Solid Tumors | Postmenopausal Women | Growth Factor | Breast Cancer
    Javier Cortés #2
    Javier Cortés
    From the International Breast Cancer Center, Quirónsalud Gro
    Known for Advisory Consultancy | Etirinotecan Pegol | Phase Iii | Brain Metastases | Breast Cancer

    Graham A Ross #3
    Graham A Ross
    F. Hoffmann-La Roche Ltd., Basel, Switzerland; | AstraZeneca
    Known for Pertuzumab Trastuzumab | Cell Lung | Breast Cancer | Phase Iii | Oral Topotecan
    Vladimir Fedorovich Semiglazov #4
    Vladimir Fedorovich Semiglazov
    NN Petrov Research Inst of Oncology, St. Petersburg, Russian
    Known for Estrogen Receptors | Neoadjuvant Chemotherapy | Pathological Complete Response | Phase Iii | Breast Cancer
    Seock Ah Im #5
    Seock Ah Im
    Cancer Research Institute, Seoul National University, Seoul,
    Known for Neoadjuvant Chemotherapy | Advisory Consultancy | Grant Funding | Premenopausal Women | Breast Cancer
    Sandra Meta Swain #6
    Sandra Meta Swain
    Georgetown University Medical Center, Washington, WA; | Geor
    Known for Adjuvant Chemotherapy | Pertuzumab Trastuzumab | Nrg Oncology | Monoclonal Antibodies | Breast Cancer
    Tadeusz Pienkowski #7
    Tadeusz Pienkowski
    Postgraduate Medical Education Center. | Postgraduate Medica
    Known for Trastuzumab Docetaxel | 5 Years | Phase Iii | Estrogen Receptors | Breast Cancer
    Luca Gianni #8
    Luca Gianni
    Fondazione Michelangelo, Milan, Italy | Gianni Bonadonna Fou
    Known for 1 Year | Monoclonal Antibodies | Trastuzumab Emtansine | Pathological Complete Response | Breast Cancer
    Young‐Hyuck Im #9
    Young‐Hyuck Im
    Medicine Dept., Hematology/Medical Oncology Division, Samsun
    Known for Neoadjuvant Chemotherapy | Endocrine Therapy | Grant Funding | Brain Metastasis | Breast Cancer
    Dennis J Slamon #10
    Dennis J Slamon
    David Geffen School of Medicine at UCLA, Los Angeles, CA; |
    Known for Monoclonal Antibodies | Situ Hybridization | Cell Lines | Her2 Neu | Breast Cancer

    Sign-in to see the full list, it's free!